Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • June 2019 •
  • 106 pages •
  • Report ID: 5783193 •
  • Format: PDF
The global pain management drugs market was worth US$ 38.9 Billion in 2018. Pain is a distressing feeling which can be caused due to various health issues such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis and cancer. Pain mechanism is an intricate process, and there are several pain management drugs that provide relief by acting through various physiological functions. These medications are specific drugs that perform pharmacological actions on pain receptors and work against the discomfort-causing symptoms.

High prevalence of chronic pain diseases and increasing geriatric population are among the key factors driving the global pain management drugs market. In 2018, around 991 Million people across the globe were more than 60 years old. By 2024, we expect these figures to reach 1.18 Billion. With the prevalence of chronic pain being significantly higher in older adults, this represents a key factor driving the demand of pain management drugs. Additionally, the increasing number of hospitalization cases, a huge demand-supply gap for effective neuropathic pain management drugs, and application of innovative and advance therapies, are also catalyzing the growth of the market. Furthermore, increasing occurrence of chronic diseases such as cancer, arthritis, heart attacks and diabetes along with neurological issues are also boosting the global demand for these drugs. Moreover, factors such as rising healthcare expenditure, improving R&D, rising consumer awareness, and significant government support for improving healthcare services are also driving the growth of the market. Looking forward, the analyst expects the market to reach US$ 52.1 Billion by 2024, exhibiting a CAGR of around 5% during 2019-2024

Report Coverage:
Historical, Current and Future Market Trends

Market Breakup by Drug Class:
NSAIDs
Anesthetics
Anticonvulsants
Antimigraine Agents
Antidepressants
Opioids
Others

Market Breakup by Indication:
Musculoskeletal Pain
Surgical and Trauma Pain
Cancer Pain
Neuropathic Pain
Migraine Pain
Obstetrical Pain
Fibromyalgia Pain
Burn Pain
Dental/Facial Pain
Pediatric Pain
Others

Market Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Inc., Pfizer, Inc., Eli Lilly & Company, Endo Health Solutions, Inc., F. Hoffmann La Roche Ltd., Valeant Pharmaceuticals International Inc., Merck & Co. Inc., Allergen Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline Plc, Purdue Pharma L.P., etc.

Key Questions Answered in This Report:
How has the global pain management drugs market performed so far and how will it perform in the coming years?
What are the key regional markets in the global pain management drugs industry?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the global pain management drugs industry?
What are the key driving factors and challenges in the global pain management drugs industry?
What is the structure of the global pain management drugs industry and who are the key players?
What is the degree of competition in the global pain management drugs industry?
What are the profit margins in the global pain management drugs industry?